Quarterly Report · 10-Q
Nexentis Technologies Inc. NXTS NASDAQ EQUITY Current
Add to THEMA watchlist → Follow this company’s filings → Quarterly Report Filed Aug 13, 2026 Accepted Aug 13, 2026, 4:06 PM EDT CIK 1789192 Accession 0001493152-26-037757
Company context We are focused on sustainable operations in various industries such as biotechnology and solar projects. Our activities are advancing innovative drug development solutions through MitoCareX to improve treatments for cancer and inflammatory metabolic diseases.
Current securities Historical securities (1) Registered securities in this filing NEXENTIS TECHNOLOGIES INC. · 10-Q · Filed 2026-08-13
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.0001 per share
Exchange NASDAQ
Classification COMMON
Status Current Filing context Context: From2026-01-01to2026-06-30
Dimensions: Not supplied
Accession 000149315226037757 · 1 registered-security cover member
Read the exact SEC filing ↗
As-filed source Primary evidence